This is a preview of subscription content, log in via an institution to check access.
References
Andersson, L. C., Jokinen, M., and Gahmberg, C. G.: Induction of erythroid differentiation in the human leukaemia cell line K562. Nature 278: 364–365, 1979
Arce-Gomez, B., Jones, E. A., Barnstable, C. J., Solomon, E., and Bodmer, W. F.: The genetic control of HLA-A and B antigens in somatic cell hybrids: the requirement for beta 2-microglobulin. Tissue Antigens 11: 96–112, 1978
Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F., and Ziegler, A.: Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-New tools for genetic analysis. Cell 14: 9–20, 1978
Benz, E. J., Murnane, M. J., Tonkonow, B. L., Berman, B. W., Mazur, E. M., Cavallesco, C., Jenko, T., Snyder, E. L., Forget, B. G., and Hoffman, R.: Embryonic-fetal erythroid characteristics of a human leukemic cell line. Proc. Natl. Acad. Sci. U.S.A. 77: 3509–3513, 1980
Borsos, T., Loos, M., Chapuis, R. M., Medicus, R., and Isliker, H.: A novel way of relating the structure of Clq to the hemolytic activity of the first component of complement. Mol. Immunol. 17: 1415–1421, 1980
Brown, G., Biberfeld, P., Christensson, B., and Mason, D. Y.: The distribution of HLA on human lymphoid, bone marrow and peripheral blood cells. Eur. J. Immunol. 9: 272–275, 1979
Drew, S. I., Terasaki, P. I., Billing, R. J., Bergh, O. J., Minowada, J., and Klein, E.: Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker. Blood 49: 715–718, 1977
Fellous, M., Mortchelewicz, F., Kamoun, M., and Dausset, J.: The use of a lymphoid cell line to define new B lymphocyte specificities, probably controlled by the MHC region. In F. Kissmeyer-Nielsen (ed.): Histocompatibility Testing, pp. 708–712, Munksgaard, Copenhagen, 1975
Fellous, M., Kamoun, M., Wiels, J., Dausset, J., Clements, G., Zeuthen, J., and Klein, G.: Induction of HLA expression in Daudi cells after cell fusion. Immunogenetics 5: 423–436, 1977
Gallagher, R., Collins, S., Trujillo, J., McKredie, K., Ahearn, M., Tsai, T., Metzgar, R., Aulakh, G., Ting, R., Ruscetti, F., and Gallo, R.: Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54: 713–733, 1979
Harrison, P. R.: New human myeloid leukaemia cell line undergoes red shift. Nature 281: 632–633, 1979
Heinrichs, H., Wernet, P., and Ziegler, A.: Expression of major histocompatibility antigens on human thymocytes studied using monoclonal antibodies. Immunogenetics 11: 629–635, 1980
Howard, J. C., Butcher, G. W., Galfre, G., Milstein, C., and Milstein, C. P.: Monoclonal antibodies as tools to analyze the serological and genetic complexities of major transplantation antigens. Immunol. Rev. 47: 139–174, 1979
Jones, E. A., Goodfellow, P. N., Bodmer, J. G., and Bodmer, W. F.: Serological identification of HL-Alinked human ‘la-type’ antigens. Nature 256: 650–652, 1975
Jones, E. A. and Bodmer, W. F.: Lack of expression of HLA antigens on choriocarcinoma cell lines. Tissue Antigens 16: 195–202, 1980
Klein, G., Zeuthen, J., Eriksson, I., Terasaki, P., Bernoco, M., Rosén, A., Masucci, G., Povey, S., and Ber, R.: Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1). J. Natl. Cancer Inst. 64: 725–738, 1980
Laskey, R. A. and Mills, A. D. Enhanced autoradiographic detection of 32P and 125I using intensifying screens and hypersensitized films. FEBS Lett. 82: 314–316, 1977
Lozzio, C. B. and Lozzio, B. B.: Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45: 321–334, 1975
Ortaldo, J. R., Oldham, R. K., Cannon, G. C., and Herberman, R. B.: Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line. J. Natl. Cancer Inst. 59: 77–83, 1977
Roy, J. G., Hare, B.B., and Pedersen, P. D. (eds.): Manual of Tissue Typing Techniques, DREW publication no. NIH 75-545, Government Printing Office, Washington D. C., 1974
Rutherford, T. R., Clegg, J. B., and Weatherall, D. J.: K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature 280: 164–165, 1979
Seeley, J. K., Masucci, G., Poros, A., Klein, E., and Golub, S. H.: Studies on cytotoxicity generated in human mixed lymphocyte cultures. II. Anti-K562 effectors are distinct from allospecific CTL and can be generated from NK-depleted T cells. J. Immunol. 123: 1303–1311, 1979
Uchanska-Ziegler, B., Wernet, P., and Ziegler, A.: Rapid preparation of multiple cell samples for immunofluorescence analysis using microtiter plates. J. Immunol. Methods 39: 85–93, 1980
Zarling, J. M. and Kung, P. C.: Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes. Nature 288: 394–396, 1980
Zeuthen, J., Friedrich, U., Rosén, A., and Klein, E.: Structural abnormalities in chromosome 15 in cell lines with reduced expression of beta-2-microglobulin. Immunogenetics 4: 567–580, 1977
Ziegler, A. and Pink, J. R. L.: Chemical properties of two antigens controlled by the major histocompatibility complex of the chicken. J. Biol. Chem. 251: 5391–5396, 1976
Ziegler, A. and Milstein, C.: A small polypeptide different from β2-microglobulin associated with a human cell surface antigen. Nature 279: 243–244, 1979
Ziegler, A., Uchanska-Ziegler, B., Rosenfelder, G., Braun, D. G., and Werner, P.: Heterogeneity of established human hematopoietic cell lines: surface antigens detected by monoclonal antibodies and glycosphingolipid patterns. In W. Knapp (ed.): Leukemia Markers, Academic Press, London, in press, 1981
Zinkernagel, R. M.: H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. The H-2 K structure involved is coded by a single cistron defined by H-2Kb mutant mice. J. Exp. Med. 143: 437–451, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ziegler, A., Laudien, D., Heinrichs, H. et al. K562 cells express human major histocompatibility antigens. Immunogenetics 13, 359–365 (1981). https://doi.org/10.1007/BF00364503
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00364503